InnoSIGN is a start-up company based at the High Tech Campus in Eindhoven (NL) and in Mason, Ohio (US). We are passionate to bring our OncoSIGNal pathway activity profiling technology to cancer patients contributing to a better understanding of disease mechanisms in oncology. Our product OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior, facilitating to improve personalized treatment of patients.